Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2021-09-09 · Food and Drug Administration, HHS · Rules and Regulations

Rules and Regulations. Notification of petition

398 words·~2 min read·/register/2021/09/09/2021-19409·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Agency: Food and Drug Administration, HHS
Action: Notification of petition
Citation: FR Doc. 2021-19409 · Docket No. FDA-2021-F-0926 · 21 CFR 172

Summary

The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by Monaghan Mushrooms Ireland Unlimited Company, proposing that the food additive regulations be amended to provide for the safe use of vitamin D 2 mushroom powder produced by exposing dried and powdered edible cultivars of Agaricus bisporus to ultraviolet light.

Dates

The food additive petition was filed on June 8, 2021.

Supplementary Information

Under the Federal Food, Drug, and Cosmetic Act (section 409(b)(5) (21 U.S.C. 348(b)(5)), we are giving notice that we have filed a food additive petition (FAP 1A4828), submitted by Monaghan Mushrooms Ireland Unlimited Company, Tullygony, Tyholland, County Monaghan, H18 FW95, Ireland. The petition proposes to amend the food additive regulations in § 172.382 (21 CFR 172.382) Vitamin D 2 mushroom powder to provide for the safe use of vitamin D 2 mushroom powder produced by exposing dried and powdered edible cultivars of Agaricus bisporus to ultraviolet light. The petitioner has claimed that this action is categorically excluded under 21 CFR 25.32(k) because the substance is intended to remain in food through ingestion by consumers and is not intended to replace macronutrients in food. In addition, the petitioner has stated that, to their knowledge, no extraordinary circumstances exist that would warrant at least an environmental assessment (see 21 CFR 25.21). If FDA determines a categorical exclusion applies, neither an environmental assessment nor an environmental impact statement is required. If FDA determines a categorical exclusion does not apply, we will request an environmental assessment and make it available for public inspection. Dated: September 2, 2021. Lauren K. Roth, Acting Principal Associate Commissioner for Policy. [FR Doc. 2021-19409 Filed 9-8-21; 8:45 am]

Connectionstraces to 4
1 reference not yet in our index
  • 21 CFR 172
Citation graph
cites case law
Rules and Regulations
Notification of petition
Cite21 CFR 172
Cites 5Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.